Inventor · disambiguated record
Karolina A. Meagher
Also filed as: MEAGHER KAROLINA · MEAGHER KAROLINA A
34 granted patents·20 pending applications·522 citations·filing 2012–2024
98Inventor score
Top patents by PatentIndex Score
54 records- 0199US9844212B2Human lambda light chain miceREGENERON PHARMA·Filed 2017·Granted Dec 19, 2017·15 cites·30 claims
- 0299US9226484B2Human lambda light chain miceREGENERON PHARMA·Filed 2015·Granted Jan 5, 2016·31 cites·7 claims
- 0399US9206263B2Method of making antibodies using a human lambda light chain mouseREGENERON PHARMA·Filed 2015·Granted Dec 8, 2015·33 cites·35 claims
- 0499US9206262B2Method of cloning a lambda light chain variable domain using a human lambda light chain mouseREGENERON PHARMA·Filed 2015·Granted Dec 8, 2015·20 cites·15 claims
- 0599US9163092B2Hybrid light chain miceREGENERON PHARMA·Filed 2015·Granted Oct 20, 2015·36 cites·20 claims
- 0699US9150662B2Hybrid light chain miceREGENERON PHARMA·Filed 2015·Granted Oct 6, 2015·31 cites·20 claims
- 0799US9066502B2Hybrid light chain miceREGENERON PHARMA·Filed 2013·Granted Jun 30, 2015·36 cites·13 claims
- 0899US9029628B2Human lambda light chain miceREGENERON PHARMA·Filed 2013·Granted May 12, 2015·37 cites·21 claims
- 0999US9006511B2Human lambda light chain miceREGENERON PHARMA·Filed 2013·Granted Apr 14, 2015·45 cites·7 claims
- 1098US9850462B2Human lambda light chain miceREGENERON PHARMA·Filed 2017·Granted Dec 26, 2017·9 cites·13 claims
- 1198US9540452B2Human lambda light chain miceREGENERON PHARMA·Filed 2015·Granted Jan 10, 2017·13 cites·29 claims
- 1298US9399683B2Human lambda light chain miceREGENERON PHARMA·Filed 2015·Granted Jul 26, 2016·14 cites·15 claims
- 1398US9334333B2Hybrid light chain miceREGENERON PHARMA·Filed 2015·Granted May 10, 2016·12 cites·14 claims
- 1498US9206261B2Method of making antibodies using a human lambda light chain mouseREGENERON PHARMA·Filed 2015·Granted Dec 8, 2015·19 cites·35 claims
- 1598US9113616B2Genetically modified mice having humanized TCR variable genesREGENERON PHARMA·Filed 2012·Granted Aug 25, 2015·67 cites·42 claims
- 1697US9394373B2Human lambda light chain miceREGENERON PHARMA·Filed 2014·Granted Jul 19, 2016·13 cites·23 claims
- 1797US9204624B2Non-human animals with modifed immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2014·Granted Dec 8, 2015·30 cites·27 claims
- 1896US9622459B2Humanized light chain miceREGENERON PHARMA·Filed 2013·Granted Apr 18, 2017·19 cites·20 claims
- 1995US10266803B2Human lambda light chain miceREGENERON PHARMA·Filed 2017·Granted Apr 23, 2019·4 cites·20 claims
- 2095US9930871B2Non-human animals with modified immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2015·Granted Apr 3, 2018·7 cites·27 claims
- 2193US9686970B2Mice that make VL binding proteinsREGENERON PHARMA·Filed 2013·Granted Jun 27, 2017·10 cites·6 claims
- 2293US9474255B2Non-human animals having humanized Fc-gamma receptorsREGENERON PHARMA·Filed 2015·Granted Oct 25, 2016·6 cites·21 claims
- 2392US2024327785A1Human lambda light chain miceREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2488US9963501B2B cell lineage based immunogen design with humanized animalsREGENERON PHARMA·Filed 2014·Granted May 8, 2018·6 cites·14 claims
- 2585US2024180130A1Non-human animals with modified immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2683US11528895B2Genetically modified T cell receptor miceREGENERON PHARMA·Filed 2015·Granted Dec 20, 2022·2 cites·19 claims
- 2783US10954310B2Mice that make VL binding proteinsREGENERON PHARMA·Filed 2017·Granted Mar 23, 2021·1 cites·6 claims
- 2882US2024156070A1Common light chain mouseREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2981US12486335B2Mice that make VL binding proteinsREGENERON PHARMA·Filed 2021·Granted Dec 2, 2025·0 cites·3 claims
- 3079US10865236B2Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereofREGENERON PHARMA·Filed 2018·Granted Dec 15, 2020·1 cites·16 claims
- 3179US10555507B2Non-human animals having humanized Fc-gamma receptorsREGENERON PHARMA·Filed 2016·Granted Feb 11, 2020·1 cites·22 claims
- 3279US2023232795A1Non-human animals having humanized fc-gamma receptorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3378US2022386575A1Genetically modified t cell receptor miceREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3478US2024315221A1Rodent anmals expressing human cr1REGENERON PHARMA·Filed 2024·Application pending·0 cites
- 3577US10626168B2B cell lineage based immunogen design with humanized animalsREGENERON PHARMA·Filed 2018·Granted Apr 21, 2020·1 cites·18 claims
- 3676US2021163628A1Mice that make vl binding proteinsREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 3776US2019203171A1Human lambda light chain miceREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 3876US2020239837A1Human lambda light chain miceREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 3975US2019153384A1Human lambda light chain miceREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 4074US9932398B2Restricted immunoglobulin heavy chain miceREGENERON PHARMA·Filed 2013·Granted Apr 3, 2018·1 cites·17 claims
- 4173US11503812B2Non-human animals having humanized Fc-gamma receptorsREGENERON PHARMA·Filed 2019·Granted Nov 22, 2022·0 cites·11 claims
- 4273US10765762B2Humanized model of kidney and liver disordersREGENERON PHARMA·Filed 2018·Granted Sep 8, 2020·2 cites·16 claims
- 4372US12082566B2Rodent animals expressing human CR1REGENERON PHARMA·Filed 2021·Granted Sep 10, 2024·0 cites·9 claims
- 4472US2021076648A1Non-human animals with modified immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 4569US2021368751A1Humanized rodents that express heavy chain containing vl domainsMACDONALD LYNN·Filed 2021·Application pending·0 cites
- 4667US2019090462A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 4767US2022033847A1Non-human animals expressing humanized c1q complexREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 4867US2019021295A1Common light chain mouseREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 4963US11186848B2Non-human animals expressing humanized C1Q complexREGENERON PHARMA·Filed 2018·Granted Nov 30, 2021·0 cites·25 claims
- 5063US2021147519A1Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Karolina A. Meagher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →